Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
Budesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real world study Dr. Shravani Dali7 Jun 2024 8:30 PM ISTBudesonide/Glycopyrrolate/Formoterol show promising results in COPD management in real-world study suggests a study published in the International...
Not approved as Inhalation suspension for nebulization, Conduct CT: CDSCO Panel Tells Glenmark on Pulmonary FDC Dr. Divya Colin2 April 2024 6:00 PM ISTNew Delhi: Noting that the proposed fixed-dose combination (FDC) of Glycopyrrolate plus Formoterol Fumarate Dihydrate plus Budesonide (25mcg+20mcg+500...
Conduct bioequivalence study: CDSCO Panel tells Zydus Healthcare on Glycopyrrolate, Indacaterol Metered dose inhalation Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the clinical trial waiver proposal, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol Ruchika Sharma15 Dec 2023 4:30 PM ISTBangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO)...
Zydus Healthcare Gets CDSCO panel Nod To Market Vilanterol, Glycopyrrolate FDC metered dose inhalation Dr. Divya Colin23 Nov 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Show lung deposition of triple drug combination in Inhalation Suspension: CDSCO Panel tells Glenmark on Pulmonary FDC Drug Dr. Divya Colin2 Nov 2023 5:37 PM ISTNew Delhi: In line with the proposal presented by the drug major Glenmark Pharmaceuticals for the bioequivalence (BE) and Phase III clinical trial...
Zydus Healthcare Gets CDSCO Panel Nod To Market Vilanterol, Glycopyrrolate, Fluticasone Metered Dose Inhaler Dr. Divya Colin13 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Include more Govt sites: CDSCO panel tells Glenmark on asthma drug combination Roshni Dhar9 Oct 2023 3:04 PM ISTCiting that more government sites shall be included in the study with geographical distribution, the Subject Expert Committee (SEC) functional under...
Health Bulletin 07/October/2023 Roshni Dhar7 Oct 2023 4:43 PM ISTHere are the top health stories of the day:Professional Conduct Review - Lessons from case archives: NMC unveils its first publicationThrough a recent...
Include more Govt sites: CDSCO Panel Tells Glenmark on Asthma Drug Combination Dr. Divya Colin6 Oct 2023 6:00 PM ISTNew Delhi: Citing that more government sites shall be included in the study with geographical distribution, the Subject Expert Committee (SEC)...
CDSCO panel tells Glenmark to provide in-vivo data, global data concerning Pulmonary FDC in inhalation suspension Roshni Dhar1 Oct 2023 3:15 PM ISTIn reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary drug...
